Bristol-Myers Squibb Co at Cowen Health Care Conference Transcript
(technical difficulty) to the Cowen conference. Representing the company is Samit Hirawat, who is Executive Vice President and Chief Medical Officer and the Global Head of Drug Development. So thanks, Samit for making the time to be with us. Lots to talk about, lots going on in the Bristol pipeline. So we'll jump right in.
Questions & Answers
Let's start with Sotyktu, which is off to just a terrific start in the marketplace for psoriasis. You're working on a number of other indications. Those are in development.
Can you kind of order them relative to your conviction and/or the market potential? And just remind us where those additional indications for Sotyktu stand today?
Sure. Thanks, Steve, for the question. And
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
